Procaps Operating Margin from 2010 to 2025

PROCW Stock  USD 0.03  0.0002  0.66%   
Procaps Group Operating Profit Margin yearly trend continues to be fairly stable with very little volatility. Operating Profit Margin will likely drop to 0.11 in 2025.
Check Procaps Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procaps Group's main balance sheet or income statement drivers, such as Tax Provision of 12.7 M, Depreciation And Amortization of 13 M or Interest Expense of 40.4 M, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0 or Days Sales Outstanding of 87.22. Procaps financial statements analysis is a perfect complement when working with Procaps Group Valuation or Volatility modules.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Latest Procaps Group's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Procaps Group SA over the last few years. It is Procaps Group's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procaps Group's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.11 %10 Years Trend
Very volatile
   Operating Profit Margin   
       Timeline  

Procaps Operating Margin Regression Statistics

Arithmetic Mean0.11
Coefficient Of Variation34.37
Mean Deviation0.02
Median0.11
Standard Deviation0.04
Sample Variance0
Range0.195
R-Value0.05
Mean Square Error0
R-Squared0
Significance0.86
Slope0.0004
Total Sum of Squares0.02

Procaps Operating Margin History

2024 0.15
2022 0.13
2021 -0.0129
2020 0.18

About Procaps Group Financial Statements

Procaps Group investors use historical fundamental indicators, such as Procaps Group's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Procaps Group. Please read more on our technical analysis and fundamental analysis pages.
Procaps Group, S.A. develops, manufactures, and markets over-the-counter and prescription drugs, nutritional supplements, and clinical solutions. The company was founded in 1977 and is based in Luxembourg City, Luxembourg Procaps Group is traded on NASDAQ Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Procaps Stock Analysis

When running Procaps Group's price analysis, check to measure Procaps Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procaps Group is operating at the current time. Most of Procaps Group's value examination focuses on studying past and present price action to predict the probability of Procaps Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procaps Group's price. Additionally, you may evaluate how the addition of Procaps Group to your portfolios can decrease your overall portfolio volatility.